お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はセルフリーDNA（cfDNA）検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはセルフリーDNA（cfDNA）検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のセルフリーDNA（cfDNA）検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはセルフリーDNA（cfDNA）検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にセルフリーDNA（cfDNA）検査市場を分類しています。本研究に含まれる主な企業は：Agilent Technology、Allenex、Biocept、Biodesix、CareDx、Guardant Health、Illumania、Invited、Natera、Quest Diagnostics、Roche Holdings、Sequenom、Trovagene

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Donor-Derived Cell-Free DNA (DdcfDNA)
    Circulating Cell-Free Tumor DNA (CtDNA)
    Cell-Free Fetal DNA (NIPT)

用途別の市場セグメント：
    Hospital
    Ambulatory Surgical Centers
    Cancer Research Institutes

本レポートの詳細内容
世界のセルフリーDNA（cfDNA）検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、セルフリーDNA（cfDNA）検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のセルフリーDNA（cfDNA）検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のセルフリーDNA（cfDNA）検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、セルフリーDNA（cfDNA）検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

セルフリーDNA（cfDNA）検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：セルフリーDNA（cfDNA）検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：セルフリーDNA（cfDNA）検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章セルフリーDNA（cfDNA）検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：セルフリーDNA（cfDNA）検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：セルフリーDNA（cfDNA）検査の主要企業の概要を提供し、製品の説明と仕様、セルフリーDNA（cfDNA）検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.
Market Analysis and Insights: Global Cell-Free DNA (cfDNA) Testing Market
The global Cell-Free DNA (cfDNA) Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market.

Report Covers:
This report presents an overview of global market for Cell-Free DNA (cfDNA) Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Cell-Free DNA (cfDNA) Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell-Free DNA (cfDNA) Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell-Free DNA (cfDNA) Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cell-Free DNA (cfDNA) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cell-Free DNA (cfDNA) Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Agilent Technology, Allenex, Biocept, Biodesix, CareDx, Guardant Health, Illumania, Invited and Natera, etc.

Market Segmentation
By Company
    Agilent Technology
    Allenex
    Biocept
    Biodesix
    CareDx
    Guardant Health
    Illumania
    Invited
    Natera
    Quest Diagnostics
    Roche Holdings
    Sequenom
    Trovagene

Segment by Type
    Donor-Derived Cell-Free DNA (DdcfDNA)
    Circulating Cell-Free Tumor DNA (CtDNA)
    Cell-Free Fetal DNA (NIPT)

Segment by Application
    Hospital
    Ambulatory Surgical Centers
    Cancer Research Institutes

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell-Free DNA (cfDNA) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Free DNA (cfDNA) Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell-Free DNA (cfDNA) Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
    Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
    Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
    Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2019-2024)
    Table 9. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2025-2030)
    Table 11. Cell-Free DNA (cfDNA) Testing Market Trends
    Table 12. Cell-Free DNA (cfDNA) Testing Market Drivers
    Table 13. Cell-Free DNA (cfDNA) Testing Market Challenges
    Table 14. Cell-Free DNA (cfDNA) Testing Market Restraints
    Table 15. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Players (2019-2024)
    Table 17. Global Top Cell-Free DNA (cfDNA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2023)
    Table 18. Global Cell-Free DNA (cfDNA) Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Cell-Free DNA (cfDNA) Testing, Headquarters and Area Served
    Table 21. Global Key Players of Cell-Free DNA (cfDNA) Testing, Product and Application
    Table 22. Global Key Players of Cell-Free DNA (cfDNA) Testing, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2019-2024)
    Table 26. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2025-2030)
    Table 28. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Application (2019-2024)
    Table 30. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Application (2025-2030)
    Table 32. North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Cell-Free DNA (cfDNA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Cell-Free DNA (cfDNA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Cell-Free DNA (cfDNA) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Cell-Free DNA (cfDNA) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Cell-Free DNA (cfDNA) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Cell-Free DNA (cfDNA) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Cell-Free DNA (cfDNA) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Cell-Free DNA (cfDNA) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Cell-Free DNA (cfDNA) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Cell-Free DNA (cfDNA) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Cell-Free DNA (cfDNA) Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Cell-Free DNA (cfDNA) Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Cell-Free DNA (cfDNA) Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Agilent Technology Company Details
    Table 65. Agilent Technology Business Overview
    Table 66. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
    Table 67. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 68. Agilent Technology Recent Developments
    Table 69. Allenex Company Details
    Table 70. Allenex Business Overview
    Table 71. Allenex Cell-Free DNA (cfDNA) Testing Product
    Table 72. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 73. Allenex Recent Developments
    Table 74. Biocept Company Details
    Table 75. Biocept Business Overview
    Table 76. Biocept Cell-Free DNA (cfDNA) Testing Product
    Table 77. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 78. Biocept Recent Developments
    Table 79. Biodesix Company Details
    Table 80. Biodesix Business Overview
    Table 81. Biodesix Cell-Free DNA (cfDNA) Testing Product
    Table 82. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 83. Biodesix Recent Developments
    Table 84. CareDx Company Details
    Table 85. CareDx Business Overview
    Table 86. CareDx Cell-Free DNA (cfDNA) Testing Product
    Table 87. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 88. CareDx Recent Developments
    Table 89. Guardant Health Company Details
    Table 90. Guardant Health Business Overview
    Table 91. Guardant Health Cell-Free DNA (cfDNA) Testing Product
    Table 92. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 93. Guardant Health Recent Developments
    Table 94. Illumania Company Details
    Table 95. Illumania Business Overview
    Table 96. Illumania Cell-Free DNA (cfDNA) Testing Product
    Table 97. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 98. Illumania Recent Developments
    Table 99. Invited Company Details
    Table 100. Invited Business Overview
    Table 101. Invited Cell-Free DNA (cfDNA) Testing Product
    Table 102. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 103. Invited Recent Developments
    Table 104. Natera Company Details
    Table 105. Natera Business Overview
    Table 106. Natera Cell-Free DNA (cfDNA) Testing Product
    Table 107. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 108. Natera Recent Developments
    Table 109. Quest Diagnostics Company Details
    Table 110. Quest Diagnostics Business Overview
    Table 111. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
    Table 112. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 113. Quest Diagnostics Recent Developments
    Table 114. Roche Holdings Company Details
    Table 115. Roche Holdings Business Overview
    Table 116. Roche Holdings Cell-Free DNA (cfDNA) Testing Product
    Table 117. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 118. Roche Holdings Recent Developments
    Table 119. Sequenom Company Details
    Table 120. Sequenom Business Overview
    Table 121. Sequenom Cell-Free DNA (cfDNA) Testing Product
    Table 122. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 123. Sequenom Recent Developments
    Table 124. Trovagene Company Details
    Table 125. Trovagene Business Overview
    Table 126. Trovagene Cell-Free DNA (cfDNA) Testing Product
    Table 127. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
    Table 128. Trovagene Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Cell-Free DNA (cfDNA) Testing Market Share by Type: 2023 VS 2030
    Figure 3. Donor-Derived Cell-Free DNA (DdcfDNA) Features
    Figure 4. Circulating Cell-Free Tumor DNA (CtDNA) Features
    Figure 5. Cell-Free Fetal DNA (NIPT) Features
    Figure 6. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Cancer Research Institutes Case Studies
    Figure 11. Cell-Free DNA (cfDNA) Testing Report Years Considered
    Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Cell-Free DNA (cfDNA) Testing Market Share by Region: 2023 VS 2030
    Figure 15. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2023
    Figure 16. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2023
    Figure 18. North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Cell-Free DNA (cfDNA) Testing Market Share by Type (2019-2030)
    Figure 20. North America Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2030)
    Figure 21. North America Cell-Free DNA (cfDNA) Testing Market Share by Country (2019-2030)
    Figure 22. United States Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Cell-Free DNA (cfDNA) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Cell-Free DNA (cfDNA) Testing Market Share by Type (2019-2030)
    Figure 26. Europe Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2030)
    Figure 27. Europe Cell-Free DNA (cfDNA) Testing Market Share by Country (2019-2030)
    Figure 28. Germany Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Cell-Free DNA (cfDNA) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Cell-Free DNA (cfDNA) Testing Market Share by Type (2019-2030)
    Figure 36. China Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2030)
    Figure 37. Asia Cell-Free DNA (cfDNA) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Cell-Free DNA (cfDNA) Testing Market Share by Type (2019-2030)
    Figure 39. Asia Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2030)
    Figure 40. Asia Cell-Free DNA (cfDNA) Testing Market Share by Region (2019-2030)
    Figure 41. Japan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Cell-Free DNA (cfDNA) Testing Market Share by Country (2019-2030)
    Figure 51. Brazil Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 58. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 59. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 60. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 61. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 62. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 63. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 64. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 65. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 66. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 67. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 68. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 69. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed